Identification of a motif within the 5' regulatory region of pS2 which is responsible for AP-1 binding and TCDD-mediated suppression

Biochemistry
B E GillesbyT R Zacharewski

Abstract

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds modulate several endocrine systems by altering hormone synthesis, enhancing ligand metabolism, and down-regulating receptor levels/binding activity. Previous studies have demonstrated that TCDD inhibits the 17beta-estradiol (E2)-induction of pS2, a human breast cancer prognostic marker. This inhibition occurs at the gene expression level and is Ah receptor (AhR)-mediated. Analysis of the 5' regulatory region has identified three motifs which resemble dioxin response element (DRE) core sequences. pS2-regulated luciferase deletion constructs identified the DRE-like motif located at -527 to -514 as being required for TCDD-mediated suppression. A point mutation within this core motif (T-518C) abolished the inhibition by TCDD while UV-induced protein-DNA cross-linking and competitive gel retardation assays demonstrated AhR complex binding to this motif. Further study of this region also revealed an adjacent putative AP-1 site, diverging by one base pair from the consensus sequence. Gel retardation assays using TPA-treated MCF-7 cell nuclear extracts showed an induced complex binding to the AP-1-like site. Competition studies and antibody supershifts confirmed that the ...Continue Reading

References

Apr 15, 1992·Biochemical and Biophysical Research Communications·M EmaY Fujii-Kuriyama
Sep 9, 1992·International Journal of Cancer. Journal International Du Cancer·F C KoernerL H Schwartz
Jan 1, 1990·Annual Review of Pharmacology and Toxicology·J P Whitlock
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J HapgoodJ A Gustafsson
Jan 1, 1989·The International Journal of Biochemistry·D W Nebert, J E Jones
Nov 15, 1989·International Journal of Cancer. Journal International Du Cancer·Y LuqmaniG Ryall
Jan 1, 1988·Journal of Steroid Biochemistry·A E Wakeling, J Bowler
Jan 1, 1995·Annual Review of Pharmacology and Toxicology·O Hankinson
Dec 1, 1995·Mutation Research·H C Pitot
Jan 1, 1996·Annual Review of Physiology·B E Sands, D K Podolsky

❮ Previous
Next ❯

Citations

Sep 4, 2013·Seminars in Immunopathology·Francisco J Quintana
Jun 8, 2002·Archives of Biochemistry and Biophysics·Christoph KöhleJacqueline McGuire
Dec 26, 2001·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Charbel MassaadSamir Hamamah
Sep 18, 1998·Biochimica Et Biophysica Acta·S RibierasM C Rio
Aug 26, 2004·Nucleic Acids Research·Y V SunT R Zacharewski
Jul 4, 2009·Toxicological Sciences : an Official Journal of the Society of Toxicology·Shaimaa AhmedJason Matthews
Sep 6, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Michelle M AngrishTimothy R Zacharewski
Jun 19, 2013·Toxicological Sciences : an Official Journal of the Society of Toxicology·Stephen SafeUn-Ho Jin
Jan 15, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Margarita M IvanovaCarolyn M Klinge
May 23, 1998·Annual Review of Pharmacology and Toxicology·S H Safe
Jun 7, 2006·Biological & Pharmaceutical Bulletin·Yuichiro KannoYoshio Inouye
Jan 6, 2000·Archives of Biochemistry and Biophysics·C M KlingeH I Swanson
Mar 31, 2005·Reproduction : the Official Journal of the Society for the Study of Fertility·P PocarS Hombach-Klonisch
May 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Sara BrunnbergIngemar Pongratz
Sep 27, 2014·International Journal of Molecular Sciences·Fanny L'HéritierLuc Gaudreau
Jul 5, 2005·Expert Opinion on Investigational Drugs·S SafeA McDougal
Aug 23, 2006·Expert Opinion on Drug Metabolism & Toxicology·Preeti RamadossGary H Perdew
Jun 30, 2007·Toxicology and Applied Pharmacology·Shaheen KhanStephen Safe

❮ Previous
Next ❯

Related Concepts